BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19996322)

  • 1. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
    Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
    Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate pharmacokinetics in early period following lung or heart transplantation.
    Ensom MH; Partovi N; Decarie D; Ignaszewski AP; Fradet GJ; Levy RD
    Ann Pharmacother; 2003 Dec; 37(12):1761-7. PubMed ID: 14632536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.
    Mathew BS; Fleming DH; Annapandian VM; Prasanna S; Prasanna CG; Chandy SJ; John GT
    Ther Drug Monit; 2010 Apr; 32(2):136-40. PubMed ID: 20110849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Ignaszewski AP; Ensom MH
    J Heart Lung Transplant; 2008 Mar; 27(3):325-8. PubMed ID: 18342756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
    Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
    Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients.
    Johnson AG; Rigby RJ; Taylor PJ; Jones CE; Allen J; Franzen K; Falk MC; Nicol D
    Clin Pharmacol Ther; 1999 Nov; 66(5):492-500. PubMed ID: 10579476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Pharmacotherapy; 2006 Sep; 26(9):1232-40. PubMed ID: 16945044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials.
    Barraclough KA; Isbel NM; Staatz CE
    Transplantation; 2010 Jul; 90(1):44-51. PubMed ID: 20463644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
    de Winter BC; van Gelder T; Mathot RA; Glander P; Tedesco-Silva H; Hilbrands L; Budde K; van Hest RM
    Ther Drug Monit; 2009 Oct; 31(5):585-91. PubMed ID: 19704401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.